Abcellera Biologics Inc
F:8QQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abcellera Biologics Inc
F:8QQ
|
CA |
|
T
|
TFI International Inc
F:9TF
|
CA |
|
AngloGold Ashanti Ltd
F:AOD1
|
ZA |
|
P
|
PICC Property and Casualty Co Ltd
SWB:PJC
|
CN |
|
I
|
Immersion Corp
SWB:IMV
|
US |
|
S
|
Sarepta Therapeutics Inc
XBER:AB3A
|
US |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
S
|
Sixt SE
XHAM:SIX2
|
DE |
|
Seven Group Holdings Ltd
F:9SG
|
AU |
|
B
|
Bavarian Nordic A/S
LSE:0DPB
|
DK |
|
U
|
UltraGreen.ai Ltd
SGX:ULG
|
SG |
|
C
|
Cardinal Infrastructure Group Inc
NASDAQ:CDNL
|
US |
|
Galecto Inc
NASDAQ:DMRA
|
DK |
|
Rumble Inc
NASDAQ:RUM
|
US |
|
Edia Co Ltd
TSE:3935
|
JP |
|
American Airlines Group Inc
LSE:0HE6
|
US |
|
P
|
Paladin Energy Ltd
SWB:PUR
|
AU |
Multiples-Based Value
The Multiples-Based Value for
Abcellera Biologics Inc (8QQ) under the Base Case is hidden
EUR.
Compared with the current market price of 5.04 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.